Allarity Therapeutics Statistics
Total Valuation
ALLR has a market cap or net worth of $18.18 million. The enterprise value is $2.84 million.
Important Dates
The last earnings date was Friday, November 14, 2025, before market open.
| Earnings Date | Nov 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ALLR has 15.81 million shares outstanding. The number of shares has increased by 2,079.27% in one year.
| Current Share Class | 15.81M |
| Shares Outstanding | 15.81M |
| Shares Change (YoY) | +2,079.27% |
| Shares Change (QoQ) | -5.17% |
| Owned by Insiders (%) | 0.16% |
| Owned by Institutions (%) | 6.53% |
| Float | 15.79M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 1.56 |
| P/TBV Ratio | 1.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.12.
| Current Ratio | 2.33 |
| Quick Ratio | 2.11 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -84.60 |
Financial Efficiency
Return on equity (ROE) is -122.61% and return on invested capital (ROIC) is -76.73%.
| Return on Equity (ROE) | -122.61% |
| Return on Assets (ROA) | -51.62% |
| Return on Invested Capital (ROIC) | -76.73% |
| Return on Capital Employed (ROCE) | -141.57% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.19M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +8.49% in the last 52 weeks. The beta is 0.24, so ALLR's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | +8.49% |
| 50-Day Moving Average | 1.37 |
| 200-Day Moving Average | 1.14 |
| Relative Strength Index (RSI) | 45.63 |
| Average Volume (20 Days) | 192,204 |
Short Selling Information
The latest short interest is 375,614, so 2.38% of the outstanding shares have been sold short.
| Short Interest | 375,614 |
| Short Previous Month | 378,752 |
| Short % of Shares Out | 2.38% |
| Short % of Float | 2.38% |
| Short Ratio (days to cover) | 1.21 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -17.00M |
| Pretax Income | -15.31M |
| Net Income | -15.31M |
| EBITDA | -16.97M |
| EBIT | -17.00M |
| Earnings Per Share (EPS) | -$1.33 |
Full Income Statement Balance Sheet
The company has $16.90 million in cash and $1.39 million in debt, giving a net cash position of $15.51 million or $0.98 per share.
| Cash & Cash Equivalents | 16.90M |
| Total Debt | 1.39M |
| Net Cash | 15.51M |
| Net Cash Per Share | $0.98 |
| Equity (Book Value) | 12.01M |
| Book Value Per Share | 0.75 |
| Working Capital | 11.68M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$14.78 million and capital expenditures -$298,000, giving a free cash flow of -$15.08 million.
| Operating Cash Flow | -14.78M |
| Capital Expenditures | -298,000 |
| Free Cash Flow | -15.08M |
| FCF Per Share | -$0.95 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ALLR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2,079.27% |
| Shareholder Yield | -2,079.27% |
| Earnings Yield | -83.48% |
| FCF Yield | -82.22% |
Analyst Forecast
The average price target for ALLR is $9.25, which is 704.35% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.25 |
| Price Target Difference | 704.35% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on September 11, 2024. It was a reverse split with a ratio of 1:30.
| Last Split Date | Sep 11, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:30 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |